Developing therapeutic strategies to target MCL1 and BCLXL in lethal prostate cancer

Summary: Targeting anti-apoptotic BCL2 family proteins is an attractive therapeutic strategy to drive prostate cancer (PCa) cell death. Here, we show that MCL1 is highly expressed in castration-resistant PCa, associating with worse clinical outcome. We demonstrate that targeting MCL1 with BH3 mimeti...

Descripció completa

Dades bibliogràfiques

Autors principals:	Daniel Westaby, Juan M. Jiménez-Vacas, Ines Figueiredo, Jonathan Welti, Bora Gurel, Denisa Bogdan, Lorenzo Buroni, Antje J. Neeb, Jan Rekowski, Ana Padilha, Souvik Das, Joe Taylor, Wanting Zeng, Nick Waldron, Thomas Goldsmith, Emily Hobern, Florian Gabel, Nicole Pandell, Susana Miranda, Maryou B. Lambros, Suzanne Carreira, Amanda Swain, Wei Yuan, Steven P. Balk, Marco Bezzi, Johann S. de Bono, Adam Sharp
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2025-12-01
Col·lecció:	iScience
Matèries:	Pharmacology molecular biology cancer
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2589004225022461
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!